DR. RONALD PRUSSICK M.D. NPI 1588647085

NPI Details

DR. Ronald Prussick, M.D. is a specialist in N Bethesda, MD with 39 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Ronald Prussick, M.D. NPI is 1588647085. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6163 EXECUTIVE BLVD
N BETHESDA, MD
ZIP 20852-901
Phone: (301) 984-3000
Fax: (301) 984-3001

The NPI 1588647085 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11622)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11422)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11442)
• Punch biopsy, first skin growth (HCPCS:11104)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 11/29/2005 and was last updated on 9/23/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.